首页> 外国专利> HUMAN MELANOMA CELLULAR LINE mel Ibr USED IN PREPARING ANTITUMOR VACCINE

HUMAN MELANOMA CELLULAR LINE mel Ibr USED IN PREPARING ANTITUMOR VACCINE

机译:人类黑素细胞系蜜用于制备抗痘疫苗

摘要

FIELD: biotechnology, medicine, oncology.;SUBSTANCE: invention relates to a novel human melanoma cellular line mel Ibr possessing stable cultural and morphological indices that is stored in the Specialized collection of cellular cultures in Cytology institute RAS at number PKKK (P) 689D. The cellular line is characterized by expression of melanoma (differentiating) markers - CD-63, HMW and cancer-testicular marker MAGE-3, the presence of histo-compatibility antigens of the first and the second class. The cellular line can be used in creature of antitumor (all-cellular, genetic engineering) vaccines used in treatment of melanoma and other malignant neoplasms. Using this cellular line provides preparing the novel effective antitumor vaccine. Invention can be used in medicine for vaccine therapy of malignant neoplasms.;EFFECT: valuable medicinal properties of cellular line.;1 tbl, 2 ex
机译:发明领域本发明涉及具有稳定的培养和形态学指数的新型人黑素瘤细胞系mel Ibr,其以PKKK(P)689D的形式储存在细胞学研究所RAS的细胞培养专业化收藏中。该细胞系的特征在于黑色素瘤(分化)标记物-CD-63,HMW和癌-睾丸标记物MAGE-3的表达,第一类和第二类组织相容性抗原的存在。该细胞系可用于治疗黑素瘤和其他恶性肿瘤的抗肿瘤疫苗(全细胞,基因工程)。使用该细胞系提供了制备新型有效的抗肿瘤疫苗。本发明可用于恶性肿瘤疫苗治疗的药物。效果:细胞系有价值的药用特性; 1 tbl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号